Patents by Inventor Salwa Elgebaly

Salwa Elgebaly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5403914
    Abstract: A chemotactic factor released from tissue in response to injury represents the initial signal that recruits neutrophils to the tissue. As released, the factor exists as a positively charged protein complex consisting of a low molecular weight active peptide factor that carries a neutral to negative charge and a weakly associated high molecular weight protein. The tissue derived complex exhibits a molecular weight of about 100,000-300,000 daltons and the factor is obtained therefrom and purified. The peptide factor is non-immune cell derived and non-serum derived and exhibits a molecular weight of approximately 3,000 daltons.
    Type: Grant
    Filed: November 13, 1992
    Date of Patent: April 4, 1995
    Assignee: The University of Connecticut
    Inventor: Salwa A. Elgebaly
  • Patent number: 5318891
    Abstract: The invention provides a diagnostic test procedure for detecting the active status of interstitial cystitis, a chronic inflammatory disease of the bladder. Determination of chemotactic activity present in fluid that has been exposed to urinary tract tissue is performed by measuring cell migration across a membrane in response to neutrophil chemotactic factors in the fluid.
    Type: Grant
    Filed: July 8, 1992
    Date of Patent: June 7, 1994
    Assignee: The University of Connecticut
    Inventor: Salwa A. Elgebaly
  • Patent number: 5091404
    Abstract: The use of cyclocreatine to preserve and/or restore the physiological functionality of muscle tissue subject to ischemia.
    Type: Grant
    Filed: October 5, 1990
    Date of Patent: February 25, 1992
    Inventor: Salwa A. Elgebaly